The Team

Mike Moore Chief Executive Officer

Mike is a seasoned entrepreneur. He has been a principal and founder in over a dozen companies in a wide variety of industries, including software, manufacturing, mining, wireless technology, medical, 3-D publishing and oil trading companies. Mike has worked on technology development projects for NASA.

Mike has recently retired from the US Naval Reserves as a combat veteran with over 30 years of experience in areas such as electronic warfare, navigation, logistics, intelligence, remote sensing, diplomatic relations, security and counter-insurgency and other classified projects.
He is the principal visionary, strategist and driving force behind MedWatch.

Show More Show Less

Sam Zaidspiner Chief Operating Officer

Sam is a medical device launch executive who has successfully launched dozens of products and MedTech devices over his 35-year career. In the past decade, he developed, launched, and scaled all operations for a class 2 medical device, irrisept.com, that is now in 3,000 hospitals with over 3,000,000 units sold.

In the early formative years for Irrisept®, he laid the foundation of the company for growth in all areas of the business including product development, engineering, regulatory, quality, manufacturing, supply chain, distribution, sales, customer service, and international business development. From 2000 to 2010, Zaidspiner was founder and CEO of Slingshot Product Development Group, a group of innovative engineers, designers, and scientists that launched hundreds of impactful devices and products for Fortune 500 companies and start-ups. Zaidspiner’s key strengths include balancing strategic thinking with attention to detail, building strong teams and strong relationships with strategic partners.

Show More Show Less

Bruce Matichuk, MSc, MBA, PhD Candidate Chief Technology Officer

Bruce is the Co-Founder and CTO of Health Gauge, a company that built and runs a health information platform. He has worked as the CTO for several AI-based companies. Past work has included developing an intelligent integration system based on AI planning which resulted in several patents being filed.

Installations were made at several large sites including IBM, Apple, Lockheed Martin, Liberty Mutual Insurance Corporation, United Airlines, Hallmark, and others. With another company, he released an industry first e-mail and communication system for the medical community.

Bruce has published research in the area of AI and has filed several patents relating to the use of AI in industry. Bruce’s research focus is on intelligent agents including automated code generation, visual recognition, machine learning, and conversational systems. Bruce also provides regular industry talks on the emergence and use of AI.

Bruce has an MSc in Computing Science from the University of Alberta and is completing a PhD in AI (2023).

Show More Show Less

Mark Cullivan, MBE Chief Financial Officer

Mark has over 25 years corporate experience in both public and private companies. Previously, as the CFO of an internet platform company, he steered the organization to an AMEX public listing and later managed the successful acquisition of the company. Following this endeavor, he owned a business development and marketing

company that helped raise over $150 million for small cap public companies. Additionally, in his career he served as CFO of a wireless communication technology company, director of operations for a manufacturing company, and senior sales and marketing analyst for a consumer products company.

Mark earned his master’s degree in business economics from the University of California at Santa Barbara. He is currently an instructor in the Knauss School of Business at the University of San Diego.

Show More Show Less

Kevin Kapov, DO, Capt. USN (rtrd) Chief Medical Officer - USA

Dr. Kapov held the position of Chief of Clinical Innovation for Southwest Medical, a large multispecialty group, in Las Vegas, NV, part of Optumcare. He was responsible for the creation of The Center for Clinical innovation (CCI), a translational medicine environment.The CCI sponsored a number of novel programs addressing

chronic pain, colon cancer screening and Continuous Glucose Monitoring (CGM) in the primary care setting. The CGM project team worked closely with Optum Labs and the International Diabetes Center, Minn. MN.

The team implemented staff, provider and patient training regarding the use and utility of CGM’s. The CCI team also trained resident physicians in the application and interpretation of CGM data. Over several years, Dr. Kapov refined the use of the devices and the reporting of data utilizing the Ambulatory Glucose Profile (AGP) to gain a better understanding of the impact that CGM has on diabetic care. The team installed hundreds of devices over multiple clinics. Dr. Kapov was a co-investigator in several studies at Southwest Medical that brought about improvements in the treatment care path for the patient with Type 2 Diabetes.

During his tenure with Southwest Medical, Dr. Kapov also held the position of Regional Senior Medical Director over primary care where he was directly responsible for the Adult Medicine Division presiding over 150 providers, 16 clinics, and caring for 350,000 patients and other medical entities while providing care for his own panel of patients.

Dr. Kapov retired from the U.S. Navy with over 20 years of service as a Medical Corps Officer and Flight Surgeon.

Show More Show Less

Jared P. Jones, PhD Chief Research Officer

Dr. Jones is a biochemist with extensive diabetes research experience. He has spent the last 15 years working in the health care industry. The last three years he has served as a Director of Research at UnitedHealth Group (Optum Labs). His proof-of-concept research was foundational to the development of Level2, a new,

innovative treatment for patients with type 2 diabetes. He is adept at designing and implementing proof-of-concept studies, quality improvement initiatives, and clinical trials to solve health care problems. Dr. Jones is a proponent of using a minimal viable product model (MVP model) in answering research questions, thus optimizing the speed of discovery and savvy use of research assets.

Dr. Jones has co-authored 16 medical research papers including the 2019 article: “Empowering patients and providers with more and better data: Innovative concepts in type 2 diabetes management.”

Dr. Jones earned a PhD in Biochemistry from East Carolina University, School of Medicine.

Show More Show Less

Geraldine-Cunniffe-Conlon-e1695228251762

Geraldine Cunniffe-Conlon, MD, MSc, MBA Chief Medical Officer - Europe

Dr. Cunniffe-Conlon has more than 20-years of international experience as an Ophthalmic and Oculofacial Plastic Surgeon, registered with medical regulatory bodies in both the UK and Ireland. She has authored 14 papers for leading medical journals and is a member of numerous international societies, a KOL, speaker and judging

investor panelist for startup health-related challenges and hackathons in London’s University College and School of Economics and pitch events across Los Angeles.

She has experience in R&D and data science for medical device and digital health technologies. She has also worked in the IP and regulatory environment since commencing her executive MBA in 2013. She has been active in the international start-up community as ambassador, mentor and meeting coordinator for Google Start-up Grind.

Dr. Cunniffe-Conlon has a keen interest in AI-driven data discovery and analytics, having studied AI at the Sloane School of Management, MIT. She holds a range of academic and industry qualifications including a Bachelor of Medicine from the National University of Ireland, Galway, an MSc and MBA from University College and Trinity College Dublin respectively.

Show More Show Less

Andres Tovar Director, Product Development & Manufacturing

With over 20 years of extensive experience in Product Development, Operations, and Manufacturing, Andres is a seasoned leader known for his exceptional contributions. His expertise spans across new product introduction, project management, marketing, manufacturing engineering, and commercial operations, showcasing

a proven track record of success across various organizational scales, from startups to large corporations.

Having led product development teams in Canada and managed manufacturing operations in Mexico and the US for a mid-size defense contractor, Andres brings a wealth of experience. With 19 years dedicated to the Medical Device/MedTech industry, including roles at Johnson & Johnson, he has been instrumental in launching and supporting products. Andres now spearheads product development and manufacturing efforts at MedWatch Technologies.

Andres holds a BS in Mechanical Engineering from Florida Atlantic University and is set to receive his MBA from Indiana University (Bloomington) in spring 2024, with a focus on Strategy/Leadership, Marketing, and Entrepreneurship. Beyond his professional endeavors, Andres is a passionate sports enthusiast, with a background in college swimming and multiple Ironman Triathlon races over the past two decades. He is also a certified Triathlon coach and has served as a former Track coach at a local high school.

Show More Show Less

Kyle Treude Chief Commercial Officer

Kyle Treude has over 25 years of Commercial, Market Access and Sales leadership experience with innovative, high-growth medical device organizations, primarily in diabetes technology. While at Medtronic MiniMed, he launched the first ever Continuous Glucose Monitoring System and spent 11 years with Dexcom

in several key commercial leadership roles. His leadership, collaboration and strategic business planning skills lead to consistent achievement of revenue objectives. Kyle has demonstrated ability to attract, develop and retain top talent.

Show More Show Less